About this FactMed analysis covering adverse side effect reports of ALMARL patients who developed HYPOAESTHESIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 7 individuals taking ALMARL reported HYPOAESTHESIA to the FDA. A total of 227 ALMARL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALMARL and HYPOAESTHESIA. In doing so, we compare ALMARL with other drugs that cause HYPOAESTHESIA, to help you evaluate whether or not ALMARL causes HYPOAESTHESIA. Likewise, this page shows the most highly-reported side effects of ALMARL, so you can see if HYPOAESTHESIA ranks among ALMARL's most well-known side effects.
Summary Statistics
Reports of ALMARL causing HYPOAESTHESIA: 7
Reports of any side effect of ALMARL : 227
Percentage of ALMARL patients where HYPOAESTHESIA is a reported side effect: 3.0837%

FDA reports of any drug causing HYPOAESTHESIA : 45606
Average percentage for all medicated patients where HYPOAESTHESIA is reported as a complication: 0.2858%

Physician opinion on ALMARL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALMARL:
HYPERTENSION ( 76 patients )
PARKINSON'S DISEASE ( 8 patients )
ESSENTIAL TREMOR ( 6 patients )
ATRIAL FIBRILLATION ( 4 patients )
SCHIZOPHRENIA ( 2 patients )
TREMOR ( 2 patients )
ANGINA PECTORIS ( 2 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2 patients )
PALPITATIONS ( 2 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
TACHYCARDIA ( 2 patients )
HYPERTROPHY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HYPOAESTHESIA:

TYSABRI (3765 patients)
ASPIRIN (3586 patients)
VIOXX (3554 patients)
FOSAMAX (3263 patients)
AVONEX (3214 patients)
ZOMETA (2712 patients)
HUMIRA (2398 patients)
LIPITOR (2231 patients)
LYRICA (2096 patients)
NEURONTIN (2056 patients)
ENBREL (2045 patients)
HEPARIN SODIUM INJECTION (1701 patients)
PREDNISONE (1634 patients)
SYNTHROID (1590 patients)
AREDIA (1574 patients)
LISINOPRIL (1519 patients)
XANAX (1507 patients)
NEXIUM (1491 patients)
REMICADE (1439 patients)
AMBIEN (1387 patients)
LASIX (1368 patients)
LEVAQUIN (1341 patients)
METHOTREXATE (1320 patients)
FORTEO (1306 patients)
COUMADIN (1306 patients)
SEROQUEL (1296 patients)
CELEBREX (1291 patients)
OXYCONTIN (1285 patients)
REBIF (1284 patients)
ZOLOFT (1236 patients)
GABAPENTIN (1158 patients)
ATENOLOL (1137 patients)
VICODIN (1112 patients)
HYDROCHLOROTHIAZIDE (1099 patients)
PRILOSEC (1098 patients)
PAXIL (1090 patients)
NORVASC (1052 patients)
CYMBALTA (1044 patients)
FOLIC ACID (1042 patients)
IBUPROFEN (1041 patients)
PLAVIX (1027 patients)
MAGNEVIST (1024 patients)
PROTONIX (1012 patients)
OMEPRAZOLE (1003 patients)
SIMVASTATIN (1002 patients)
VITAMIN D (999 patients)
PERCOCET (960 patients)
ALBUTEROL (955 patients)
TOPROL-XL (951 patients)
ZOCOR (929 patients)
DEXAMETHASONE (907 patients)
CRESTOR (902 patients)
ATIVAN (884 patients)
FUROSEMIDE (875 patients)
LORAZEPAM (874 patients)
PREVACID (868 patients)
LEXAPRO (854 patients)
ACETAMINOPHEN (848 patients)
DECADRON (823 patients)
OXYCODONE HCL (762 patients)
BETASERON (758 patients)
AVELOX (750 patients)
CALCIUM (734 patients)
DIOVAN (729 patients)
POTASSIUM CHLORIDE (706 patients)
ZOFRAN (705 patients)
YAZ (698 patients)
CLONAZEPAM (686 patients)
FLEXERIL (682 patients)
CHANTIX (678 patients)
DURAGESIC-100 (677 patients)
EFFEXOR (676 patients)
LEVOTHYROXINE SODIUM (675 patients)
ADVAIR DISKUS 100/50 (668 patients)
PREMARIN (667 patients)
ALPRAZOLAM (664 patients)
KLONOPIN (650 patients)
PROZAC (650 patients)
AMOXICILLIN (632 patients)
YASMIN (627 patients)
CELEXA (625 patients)
VALIUM (624 patients)
SINGULAIR (623 patients)
METFORMIN HCL (618 patients)
LORTAB (618 patients)
MORPHINE (609 patients)
ARIMIDEX (609 patients)
REVLIMID (601 patients)
TOPAMAX (601 patients)
THALIDOMIDE (593 patients)
DIGOXIN (590 patients)
VELCADE (590 patients)
WELLBUTRIN (588 patients)
BACLOFEN (587 patients)
PREDNISONE TAB (583 patients)
ALLOPURINOL (572 patients)
METOPROLOL TARTRATE (565 patients)
COMPAZINE (559 patients)
OMNISCAN (558 patients)
MULTI-VITAMINS (549 patients)
ZANTAC (547 patients)
WARFARIN SODIUM (540 patients)
LANTUS (539 patients)
TAXOTERE (534 patients)
ALLEGRA (531 patients)
GILENYA (518 patients)
DIAZEPAM (514 patients)
SANDOSTATIN LAR (513 patients)
BENADRYL (505 patients)
CIPROFLOXACIN (504 patients)
ARANESP (504 patients)
AMITRIPTYLINE HCL (499 patients)
PREDNISOLONE (497 patients)
MULTI-VITAMIN (495 patients)
FENTANYL (488 patients)
VITAMIN B-12 (482 patients)
ELAVIL (481 patients)
ZYRTEC (479 patients)
AVANDIA (475 patients)
NAPROXEN (474 patients)
ZYPREXA (474 patients)
VITAMIN E (463 patients)
XELODA (460 patients)
CLINDAMYCIN (459 patients)
DILAUDID (459 patients)
ULTRAM (459 patients)
INSULIN (455 patients)
TRAMADOL HCL (452 patients)
CIPRO (452 patients)
COREG (452 patients)
TRAZODONE HCL (446 patients)
SOMA (445 patients)
EPOGEN (444 patients)
CHEMOTHERAPEUTICS NOS (443 patients)
REGLAN (438 patients)
CLONIDINE (437 patients)
ASCORBIC ACID (435 patients)
TAMOXIFEN CITRATE (429 patients)
NITROGLYCERIN (429 patients)
FISH OIL (429 patients)
GLUCOPHAGE (415 patients)
CEPHALEXIN (412 patients)
MORPHINE SULFATE (411 patients)
MIRENA (410 patients)
EFFEXOR XR (409 patients)
BYETTA (404 patients)
SPIRIVA (402 patients)
HYDROCODONE BITARTRATE (399 patients)
CALCIUM CARBONATE (399 patients)
ZITHROMAX (399 patients)
TYLENOL (396 patients)
GLEEVEC (396 patients)
TAXOL (395 patients)
LOVENOX (394 patients)
AMLODIPINE (392 patients)
COLACE (390 patients)
FEMARA (381 patients)
TYLENOL (CAPLET) (381 patients)
ALENDRONATE SODIUM (377 patients)
ACTONEL (377 patients)
BEXTRA (373 patients)
MOTRIN (372 patients)
FLONASE (371 patients)
CYTOXAN (371 patients)
RADIATION THERAPY (370 patients)
COZAAR (367 patients)
ZETIA (365 patients)
RANITIDINE (360 patients)
FLUCONAZOLE (358 patients)
HYDROCODONE (358 patients)
VALTREX (357 patients)
PEPCID (354 patients)
EXTAVIA (353 patients)
METOPROLOL (351 patients)
ACTOS (346 patients)
CHLORHEXIDINE GLUCONATE (345 patients)
DOXYCYCLINE (344 patients)
HUMALOG (344 patients)
ACYCLOVIR (342 patients)
CITALOPRAM HYDROBROMIDE (335 patients)
KEFLEX (333 patients)
IRON (331 patients)
FLUOROURACIL (331 patients)
AUGMENTIN '125' (328 patients)
FLOMAX (327 patients)
CARBOPLATIN (327 patients)
LOPRESSOR (325 patients)
TEGRETOL (322 patients)
NIASPAN (321 patients)
PROCRIT /00909301/ (318 patients)
SKELAXIN (317 patients)
NUVARING (316 patients)
MIRALAX (314 patients)
BONIVA (314 patients)
ALTACE (313 patients)
LAMICTAL (310 patients)
RISPERDAL (310 patients)
RAMIPRIL (308 patients)
BACTRIM (308 patients)
PROMETHAZINE (308 patients)
FERROUS SULFATE TAB (307 patients)
AVASTIN (307 patients)
NASONEX (306 patients)
GLIPIZIDE (305 patients)
PAROXETINE HCL (303 patients)
DIFLUCAN (302 patients)
PLAQUENIL (301 patients)
NYSTATIN (301 patients)
VOLTAREN (298 patients)
PRAVACHOL (298 patients)
Most common side effects for patients taking ALMARL:
DEPRESSED LEVEL OF CONSCIOUSNESS (20 patients)
HALLUCINATION (15 patients)
FALL (13 patients)
HYPOGLYCAEMIA (13 patients)
PYREXIA (12 patients)
TREMOR (12 patients)
DIARRHOEA (11 patients)
HEPATIC FUNCTION ABNORMAL (11 patients)
PNEUMONIA (10 patients)
DYSARTHRIA (10 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (9 patients)
RENAL FAILURE ACUTE (9 patients)
LIVER DISORDER (9 patients)
CEREBRAL INFARCTION (8 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (8 patients)
DRUG INEFFECTIVE (8 patients)
RENAL IMPAIRMENT (8 patients)
HYPONATRAEMIA (8 patients)
INTERSTITIAL LUNG DISEASE (8 patients)
JAUNDICE (8 patients)
OEDEMA PERIPHERAL (8 patients)
CONDITION AGGRAVATED (7 patients)
DELIRIUM (7 patients)
DYSPHAGIA (7 patients)
DYSPNOEA (7 patients)
HYPOAESTHESIA (7 patients)
RHABDOMYOLYSIS (7 patients)
VOMITING (6 patients)
DELUSION (6 patients)
RESPIRATORY FAILURE (6 patients)
DYSKINESIA (6 patients)
SOMNOLENCE (6 patients)
HEPATIC NEOPLASM MALIGNANT (6 patients)
HYPERGLYCAEMIA (6 patients)
HYPOKALAEMIA (6 patients)
MOVEMENT DISORDER (6 patients)
MUSCULAR WEAKNESS (6 patients)
WHITE BLOOD CELL COUNT INCREASED (5 patients)
BLADDER CANCER (5 patients)
BLOOD ANTIDIURETIC HORMONE INCREASED (5 patients)
RESTLESSNESS (5 patients)
BLOOD OSMOLARITY DECREASED (5 patients)
PLEURAL EFFUSION (5 patients)
C-REACTIVE PROTEIN INCREASED (5 patients)
CONVULSION (5 patients)
RENAL DISORDER (5 patients)
VITH NERVE PARALYSIS (5 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (5 patients)
INTESTINAL OBSTRUCTION (5 patients)
SEPSIS (5 patients)
ROAD TRAFFIC ACCIDENT (5 patients)
MUSCULOSKELETAL PAIN (5 patients)
NAUSEA (5 patients)
ANOREXIA (4 patients)
ATELECTASIS (4 patients)
ATRIAL FIBRILLATION (4 patients)
ATRIOVENTRICULAR BLOCK (4 patients)
BLOOD CREATININE INCREASED (4 patients)
BRADYCARDIA (4 patients)
CARDIAC FAILURE (4 patients)
CONSTIPATION (4 patients)
DECREASED APPETITE (4 patients)
DEHYDRATION (4 patients)
DIZZINESS (4 patients)
PLATELET COUNT DECREASED (4 patients)
PAIN (4 patients)
HYPERTENSION (4 patients)
HYPOTHYROIDISM (4 patients)
ILEUS (4 patients)
METABOLIC ACIDOSIS (4 patients)
SMALL INTESTINE CARCINOMA (4 patients)
URINE OSMOLARITY INCREASED (4 patients)
ABASIA (3 patients)
AGGRESSION (3 patients)
PRURITUS (3 patients)
ANAEMIA (3 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (3 patients)
WHITE BLOOD CELL COUNT DECREASED (3 patients)
ASTHMA (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
RENAL FAILURE (3 patients)
BLOOD PRESSURE DECREASED (3 patients)
BLOOD PRESSURE INCREASED (3 patients)
VASCULITIS (3 patients)
CAROTID ARTERY STENOSIS (3 patients)
THERAPEUTIC AGENT TOXICITY (3 patients)
CHILLS (3 patients)
CHROMATURIA (3 patients)
PETECHIAE (3 patients)
CHRONIC LYMPHOCYTIC LEUKAEMIA (3 patients)
PORIOMANIA (3 patients)
RENAL ARTERY STENOSIS (3 patients)
PANCYTOPENIA (3 patients)
DRUG ERUPTION (3 patients)
SUDDEN ONSET OF SLEEP (3 patients)
DRUG WITHDRAWAL SYNDROME (3 patients)
VERTIGO (3 patients)
EPILEPSY (3 patients)
FACE OEDEMA (3 patients)
VOLVULUS (3 patients)
GENERALISED OEDEMA (3 patients)
GINGIVAL BLEEDING (3 patients)
HAEMORRHAGE SUBCUTANEOUS (3 patients)
HALLUCINATION, VISUAL (3 patients)
PSYCHIATRIC SYMPTOM (3 patients)
HEART RATE DECREASED (3 patients)
HELICOBACTER TEST POSITIVE (3 patients)
HEPATITIS FULMINANT (3 patients)
HYPERKALAEMIA (3 patients)
HYPOTENSION (3 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (3 patients)
LOSS OF CONSCIOUSNESS (3 patients)
SENSORY DISTURBANCE (3 patients)
LYMPHOMA (3 patients)
MALAISE (3 patients)
MARKEDLY REDUCED DIETARY INTAKE (3 patients)
RENAL TUBULAR DISORDER (3 patients)
NEOPLASM MALIGNANT (3 patients)
SINUS ARREST (3 patients)
ABDOMINAL DISCOMFORT (2 patients)
ABDOMINAL PAIN (2 patients)
ACUTE MYELOID LEUKAEMIA (2 patients)
STOMACH MASS (2 patients)
PERSONALITY CHANGE (2 patients)
AGITATION (2 patients)
ALTERED STATE OF CONSCIOUSNESS (2 patients)
ANAPHYLACTOID REACTION (2 patients)
ANGER (2 patients)
PRODUCTIVE COUGH (2 patients)
RENAL CYST (2 patients)
APHASIA (2 patients)
ASTHENIA (2 patients)
ATRIOVENTRICULAR BLOCK COMPLETE (2 patients)
THIRST (2 patients)
PROSTATE CANCER (2 patients)
BLOOD AMYLASE INCREASED (2 patients)
BLOOD UREA INCREASED (2 patients)
BODY TEMPERATURE INCREASED (2 patients)
SPEECH DISORDER (2 patients)
TUMOUR LYSIS SYNDROME (2 patients)
CEREBRAL HAEMORRHAGE (2 patients)
CHEST X-RAY ABNORMAL (2 patients)
COLON CANCER (2 patients)
COMA HEPATIC (2 patients)
COMPLETED SUICIDE (2 patients)
CONTUSION (2 patients)
PERFORMANCE STATUS DECREASED (2 patients)
DEFAECATION URGENCY (2 patients)
DEMENTIA ALZHEIMER'S TYPE (2 patients)
RASH PRURITIC (2 patients)
DIABETIC KETOACIDOSIS (2 patients)
DRUG INTERACTION (2 patients)
DRUG LEVEL INCREASED (2 patients)
DYSPEPSIA (2 patients)
DYSSTASIA (2 patients)
ELECTROCARDIOGRAM QT PROLONGED (2 patients)
STEVENS-JOHNSON SYNDROME (2 patients)
EPULIS (2 patients)
EXTRAOCULAR MUSCLE PARESIS (2 patients)
FACIAL PARESIS (2 patients)
FEAR (2 patients)
FEBRILE NEUTROPENIA (2 patients)
FEMORAL NECK FRACTURE (2 patients)
FOOT FRACTURE (2 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (2 patients)
GANGRENE (2 patients)
GASTRIC ULCER HAEMORRHAGE (2 patients)
GINGIVAL HYPERTROPHY (2 patients)
GLOSSOPTOSIS (2 patients)
PLEURISY (2 patients)
PHRENIC NERVE PARALYSIS (2 patients)
HAEMATEMESIS (2 patients)
HAEMATURIA (2 patients)
HAEMOGLOBIN DECREASED (2 patients)
POLLAKIURIA (2 patients)
ORAL INTAKE REDUCED (2 patients)
HEPATIC CYST (2 patients)
HEPATIC ENCEPHALOPATHY (2 patients)
HEPATITIS (2 patients)
HYPERREFLEXIA (2 patients)
HYPERTONIA (2 patients)
HYPERURICAEMIA (2 patients)
RASH PAPULAR (2 patients)
INITIAL INSOMNIA (2 patients)
RETINAL OEDEMA (2 patients)
INTESTINAL FUNCTIONAL DISORDER (2 patients)
RESPIRATION ABNORMAL (2 patients)
IRRITABILITY (2 patients)
RIB FRACTURE (2 patients)
LEG AMPUTATION (2 patients)
LYMPHADENOPATHY (2 patients)
METABOLIC ALKALOSIS (2 patients)
ORAL HERPES (2 patients)
TAKAYASU'S ARTERITIS (2 patients)
MOUTH HAEMORRHAGE (2 patients)
UNRESPONSIVE TO STIMULI (2 patients)
TOXIC SKIN ERUPTION (2 patients)
NEPHROLITHIASIS (2 patients)
SUICIDE ATTEMPT (2 patients)
VENTRICULAR FIBRILLATION (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
UPPER RESPIRATORY TRACT INFECTION (2 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (2 patients)
SHOCK HAEMORRHAGIC (2 patients)
ABDOMEN CRUSHING (1 patients)
CARDIAC FAILURE CONGESTIVE (1 patients)
EOSINOPHILIC PNEUMONIA ACUTE (1 patients)
ESSENTIAL TREMOR (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)
FUNGAL INFECTION (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALMARL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HYPOAESTHESIA and ALMARL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALMARL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALMARL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALMARL experts. If you are a healthcare provider experienced in prescribing ALMARL, please register here.

Your online appointment book for Pippa Passes Rentals & Services

Chef and Catering services in Pippa Passes
Chiropracter and Massage services in Pippa Passes
Event and Wedding Planning services in Pippa Passes
Hair Styling services in Pippa Passes
Personal Shopping services in Pippa Passes
Photography and Videography services in Pippa Passes
Private Investigation services in Pippa Passes
Website Design services in Pippa Passes

Home
Appliance Repair services in Pippa Passes
Appraisals services in Pippa Passes
Awnings services in Pippa Passes
Builder Services services in Pippa Passes
Carpentry services in Pippa Passes
Cleaning services in Pippa Passes
Decks and Porches services in Pippa Passes
Electricians services in Pippa Passes
Fireplace services in Pippa Passes
Generators services in Pippa Passes
Greenhouses and Nurseries services in Pippa Passes
Handymen services in Pippa Passes
Home Security services in Pippa Passes
HVAC services in Pippa Passes
Insulation services in Pippa Passes
Interior Design services in Pippa Passes
Landscaping services in Pippa Passes
Lawn and Yard services in Pippa Passes
Locksmiths services in Pippa Passes
Marble and Granite Experts services in Pippa Passes
Masonry services in Pippa Passes
Moving Services services in Pippa Passes
Painters services in Pippa Passes
Plumbing services in Pippa Passes
Pool and Spa services in Pippa Passes
Property Management services in Pippa Passes
Roofers services in Pippa Passes
Snow Plowing services in Pippa Passes
Solar Power Consultants services in Pippa Passes
Upholstery services in Pippa Passes
Wallpaper services in Pippa Passes
Waterproofing services in Pippa Passes
Windows services in Pippa Passes
Services - Other

© 2014 FactMed, Inc
Privacy Policy
Terms of Use